(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.
(CIDRAP News) An experimental malaria drug that has a different mechanism from older drugs cured laboratory mice with a single dose, raising hope for eventually providing a powerful new weapon against the disease in humans.
(CIDRAP News) – In a major effort to track influenza viruses in nature and learn more about how they interact with the human body, the federal government this week announced a $23-million-a-year program to fund research centers at six institutions around the country.
(CIDRAP News) A network of clinical researchers stretching from Southeast Asia to the United States is about to begin testing whether doubling the standard dosage of oseltamivir (Tamiflu) will help patients overcome either the often-deadly H5N1 avian influenza or severe seasonal flu.
(CIDRAP News) Europe braced for further spread of the H5N1 avian influenza virus today in the wake of reports that the virus was suspected in the deaths of two wild ducks on Sweden's Baltic coast and a domestic cat in Germany.
The cat was discovered last weekend on Ruegen, the island off Germany's north coast where H5N1 was first discovered on German soil, according to a Reuters report.